How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
22
GEF Quote, Financials, Valuation and Earnings
Last price:
$52.45
Seasonality move
:
2.63%
Day range:
$50.71 - $51.24
52-week range:
$48.23 - $73.16
Dividend yield:
4.18%
P/E ratio:
14.62x
P/S ratio:
0.51x
P/B ratio:
1.46x
Volume:
111.3K
Avg. volume:
167.5K
1-year change:
-16.59%
Market cap:
$3B
Revenue:
$5.4B
EPS (TTM):
$3.50
Analysts' Opinion
-
Consensus RatingGreif has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $73.20, Greif has an estimated upside of 43.03% from its current price of $51.18.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $65.00 representing 100% downside risk from its current price of $51.18.
Fair Value
-
According to the consensus of 6 analysts, Greif has 43.03% upside to fair value with a price target of $73.20 per share.
GEF vs. S&P 500
-
Over the past 5 trading days, Greif has overperformed the S&P 500 by 0.74% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Greif does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Greif has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Greif reported revenues of $1.3B.
Earnings Growth
-
Greif earnings have been falling on a year-over-year basis for 8 quarters in a row. In the most recent quarter Greif reported earnings per share of $0.15.
Enterprise value:
5.8B
EV / Invested capital:
1.14x
Price / LTM sales:
0.51x
EV / EBIT:
12.73x
EV / Revenue:
1.05x
PEG ratio (5yr expected):
--
EV / Free cash flow:
38.78x
Price / Operating cash flow:
18.98x
Enterprise value / EBITDA:
8.01x
Gross Profit (TTM):
$1.1B
Return On Assets:
3.2%
Net Income Margin (TTM):
3.82%
Return On Equity:
9.54%
Return On Invested Capital:
4.25%
Operating Margin:
6.15%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $6.1B | $5.2B | $5.5B | $1.2B | $1.3B | |
| Gross Profit | $1.2B | $1.1B | $1.1B | $221.6M | $245.5M | |
| Operating Income | $678.5M | $560.6M | $438.3M | $75.8M | $77.8M | |
| EBITDA | $882.3M | $733.6M | $721.7M | $120.2M | $126.1M | |
| Diluted EPS | $7.66 | $5.78 | $3.50 | $1.17 | $0.15 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.3B | $1.7B | $1.5B | $1.4B | $1.6B | |
| Total Assets | $5.6B | $5.8B | $5.7B | $6B | $6.6B | |
| Current Liabilities | $990.5M | $1.3B | $880.5M | $882.7M | $1.2B | |
| Total Liabilities | $4.3B | $4.2B | $3.8B | $3.8B | $4.4B | |
| Total Equity | $1.3B | $1.6B | $1.9B | $2.2B | $2.2B | |
| Total Debt | $2.5B | $2.3B | $2.2B | $2.3B | $2.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $668M | $621.1M | $320.7M | $4.5M | -$30.8M | |
| Cash From Investing | -$251.5M | -$454.7M | -$623.7M | -$53.6M | -$19M | |
| Cash From Financing | -$345.5M | -$133.7M | $350.7M | $36.1M | $62.5M | |
| Free Cash Flow | $482.7M | $395.7M | $149.1M | -$52.9M | -$68.1M | |
GEF
Sector
Market Cap
$3B
$18.2M
Price % of 52-Week High
69.96%
61.38%
Dividend Yield
4.18%
0%
Shareholder Yield
0.21%
1.21%
1-Year Price Total Return
-16.59%
-17.7%
Beta (5-Year)
0.909
0.918
Dividend yield:
4.18%
Annualized payout:
$2.10
Payout ratio:
58.18%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$51.56
200-day SMA
Sell
Level
$61.23
Bollinger Bands (100)
Sell
Level
54.53 - 65.79
Chaikin Money Flow
Buy
Level
31.2M
20-day SMA
Sell
Level
$53.03
Relative Strength Index (RSI14)
Sell
Level
40.71
ADX Line
Sell
Level
37.23
Williams %R
Neutral
Level
-60.5615
50-day SMA
Sell
Level
$56.17
MACD (12, 26)
Sell
Level
-1.48
25-day Aroon Oscillator
Sell
Level
-60
On Balance Volume
Neutral
Level
3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.1579)
Sell
CA Score
(Annual)
Level (-0.6288)
Buy
Beneish M-Score
(Annual)
Level (-2.4887)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.6381)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.
Stock Forecast FAQ
In the current month, GEF has received 3 Buy ratings 3 Hold ratings, and 0 Sell ratings. The GEF average analyst price target in the past 3 months is $73.20.
-
Where Will Greif Stock Be In 1 Year?
According to analysts, the consensus estimate is that Greif share price will rise to $73.20 per share over the next 12 months.
-
What Do Analysts Say About Greif?
Analysts are divided on their view about Greif share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Greif is a Sell and believe this share price will drop from its current level to $65.00.
-
What Is Greif's Price Target?
The price target for Greif over the next 1-year time period is forecast to be $73.20 according to 6 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is GEF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Greif is a Leans Bullish. 3 of 6 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of GEF?
You can purchase shares of Greif via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Greif shares.
-
What Is The Greif Share Price Today?
Greif was last trading at $52.45 per share. This represents the most recent stock quote for Greif. Yesterday, Greif closed at $51.18 per share.
-
How To Buy Greif Stock Online?
In order to purchase Greif stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
